BACKGROUND: Gestational trophoblastic disease (GTD) is a heterogeneous group of disorders characterized by abnormal trophoblast tissue. Molar and non-molar hydropic placental changes are the most common forms of GTD. Differential diagnosis of GTD is sometimes problematic. Recently, p53 expression was identified as a good marker for distinguishing GTD types.
AIMS:Comparison of p53 expression in partial hydatidiform mole (PHM) and hydropic abortion.
METHODS: In this prospective cross-sectional study, molar and non-molar hydropic pregnancy specimens were collected. Immunohistochemical staining, based on the Labeled Streptavidin Biotin (LSAB) technique, was carried out on multiple 4 mm paraffin block sections prepared from formalin-fixed trophoblastic tissues. Polymer-based Envision was used to assess p53 tumor suppressor protein immunoreactivity. p53 expression was then compared between both groups.
RESULTS: In the study, 40 patients were included: 20 with confirmed PHM and 20 with hydropic pregnancy. p53 protein was positive in 60% of patients with PHM and 25% of patients with hydropic pregnancy. The p53 positive rate was significantly higher in patients with PHM (p = 0.027). Moreover, patients with PHM had a significantly high grade of staining (p<0.001).
CONCLUSION: Our findings indicate that immunohistochemical analysis of p53 protein can be used to distinguish PHM and hydropic pregnancy.
Chen Y X, Shen D H, Gu Y Q, Zhong P P, Xie J L, Song Q J, Zhang Y L, Wen J (2011). Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole. Chin J Pathol (Zhonghua Bing Li Xue Za Zhi), 40(10): 694–697
3
Almasi A, Almassinokiani F, Akbari P (2014). Frequency of molar pregnancies in health care centers of tehran, Iran. J Reprod Infertil, 15(3): 157–160
pmid: 25202674
4
Berchuck A, Kohler M F, Marks J R, Wiseman R, Boyd J , Bast R C Jr (1994). The p53 tumor suppressor gene frequently is altered in gynecologic cancers. Am J Obstet Gynecol, 170(1 Pt 1): 246– 252 https://doi.org/10.1016/S0002-9378(13)70310-7
pmid: 8296829
5
Carey L, Nash B M, Wright D C (2015). Molecular genetic studies of complete hydatidiform moles. Transl Pediatr, 4(2): 181–188
pmid: 26835372
6
Chiu P M, Ngan Y S, Khoo U S, Cheung A N (2001). Apoptotic activity in gestational trophoblastic disease correlates with clinical outcome: assessment by the caspase-related M30 CytoDeath antibody. Histopathology, 38(3): 243–249 https://doi.org/10.1046/j.1365-2559.2001.01065.x
pmid: 11260306
7
Singh Y A, Singh L S, Singh L R, Liyak P, Vaz A (2016) . A study of molar pregnancy at tertiary centre of India. Iosr J Dental Med Sci, 15(9): 49–52
8
Hasanzadeh M, Sharifi N, Farazestanian M , Nazemian S S , Madani Sani F (2016). Immunohistochemistry study of P53 and C-erbB-2 expression in trophoblastic tissue and their predictive values in diagnosing malignant progression of simple molar pregnancy. Iran J Cancer Prev, 9(3): e4115
pmid: 27703642
9
Masood S, Kehar S I, Shawana S, Aamir I (2015). Differential expression of p63 in hydropic and molar gestations. J Coll Physicians Surg Pak, 25(3): 198–201
pmid: 25772961
10
Ngan H Y, Seckl M J, Berkowitz R S, Xiang Y, Golfier F , Sekharan P K , Lurain J R (2015). Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet, 131(Suppl 2): S123–S126 https://doi.org/10.1016/j.ijgo.2015.06.008
pmid: 26433668
Rath G, Soni S, Prasad C P , Salhan S , Jain A K , Saxena S (2011). Bcl-2 and p53 expressions in Indian women with complete hydatidiform mole. Singapore Med J, 52(7): 502–507
pmid: 21808961
13
Schammel D P, Bocklage T (1996). p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study. Int J Gynecol Pathol, 15(2): 158–166 https://doi.org/10.1097/00004347-199604000-00011
pmid: 8786206
14
Soragni A, Janzen D M, Johnson L M, Lindgren A G, Thai-Quynh Nguyen A, Tiourin E , Soriaga A B , Lu J, Jiang L, Faull K F , Pellegrini M , Memarzadeh S , Eisenberg D S (2016). A designed inhibitor of p53 aggregation rescues p53 tumor suppression in ovarian carcinomas. Cancer Cell, 29(1): 90–103 https://doi.org/10.1016/j.ccell.2015.12.002
pmid: 26748848
15
Standard Immunohistochemistry Staining Method, Labeled Streptavidin Biotin (LSAB) Method [online]. Available from: Accessed Feb 11, 2007
16
Wei D, Wu Q, Shi H (2014). Apoptosis and p53 expression in the placental villi of females with unexplained recurrent spontaneous abortion. Exp Ther Med, 7(1): 191–194
pmid: 24348788
